申请人:Glaxo Group Limited
公开号:US05001135A1
公开(公告)日:1991-03-19
Compounds are disclosed of formula (I) ##STR1## wherein R.sub.1 represents a C.sub.1-6 alkyl group; R.sub.2 represents a hydrogen atom or a C.sub.1-3 alkyl group; n represents zero or an integer from 1 to 3; and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment of migraine, cluster headache, chronic paroxysmal hemicrania and headache associated with vascular disorders. Processes and intermediates for their preparation and pharmaceutical compositions containing them are also disclosed.
公开了式(I)的化合物##STR1##其中,R.sub.1代表C.sub.1-6烷基;R.sub.2代表氢原子或C.sub.1-3烷基;n代表零或1至3的整数;以及其药学上可接受的盐。这些化合物对于治疗偏头痛、集群头痛、慢性阵发性半边头痛和与血管障碍相关的头痛有用。还公开了它们的制备过程和中间体以及包含它们的制药组合物。